Cite
Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence
MLA
E.‐S. Xu, et al. “Decreasing Cytokeratin 17 Expression in Head and Neck Cancer Predicts Nodal Metastasis and Poor Prognosis: The First Evidence.” Clinical Otolaryngology, vol. 43, Apr. 2018, pp. 1010–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91a359488752d1817e8d9f8e891a47c6&authtype=sso&custid=ns315887.
APA
E.‐S. Xu, Muh Hwa Yang, Teh Ying Chou, T.‐Z. Hwang, T.‐T. Yang, C.‐Y. Liu, C.‐T. Hsu, & K.‐W. Liu. (2018). Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence. Clinical Otolaryngology, 43, 1010–1018.
Chicago
E.‐S. Xu, Muh Hwa Yang, Teh Ying Chou, T.‐Z. Hwang, T.‐T. Yang, C.‐Y. Liu, C.‐T. Hsu, and K.‐W. Liu. 2018. “Decreasing Cytokeratin 17 Expression in Head and Neck Cancer Predicts Nodal Metastasis and Poor Prognosis: The First Evidence.” Clinical Otolaryngology 43 (April): 1010–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....91a359488752d1817e8d9f8e891a47c6&authtype=sso&custid=ns315887.